Publications
InflammoBiota members are underlined
1. Pflegerl P., Vesely P., Hantusch B., Schlederer M., Zenz R., Janig E., Steiner G., Meixner A., Petzelbauer P., Wolf P., Soleiman A., Egger G., Moriggl R., Kishimoto T., Wagner E. F. and Kenner L (2009). Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci USA. 106: 20423-8.
2. Loy A and Pester M. (2010). Probing identity and physiology of uncultured microorganisms with isotope labeling techniques. pp. 127-146. In: Springer. Geomicrobiology: Molecular and Environmental Perspective. Edited by Barton L. L., Mandl M. and Loy A. Dordrecht Heidelberg London New York.
3. Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M, Egger G, Hassler MR, Thallinger C, Schmatz A, Turner SD, Greil R, and Kenner L. (2010). Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. Proc Natl Acad Sci USA. 107:16228-33.
4. Merkel O, Hamacher F, Sifft E, Kenner L, and Greil R (2011). Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools. Molecular Cancer Therapeutics 10: 1127‐1136.
5. Steger D, Berry D, Haider S, Horn M, Wagner M, Stocker R, and Loy A (2011) Systematic spatial bias in DNA microarray hybridization is caused by probe spot position-dependent variability in lateral diffusion. PLoS One. 6: e23727.
6. Berry D, Ben Mahfoudh K, Wagner M, and Loy A (2011) Barcoded primers used in multiplex amplicon pyrosequencing bias amplification. Appl Environ Microbiol. 77: 7846-7849.
7. Merkel O, Hamacher F, Sifft E, Kenner L, and Greil R (2011) Novel therapeutic options in anaplastic large cell lymphoma: Molecular targets and immunological tools. Mol Cancer Ther 10:1127-1136.
8. Leeb C, Jurga M, McGuckin C, Forraz N, Thallinger C, Moriggl R, and Kenner L (2011) New perspectives in stem cell research: beyond embryonic stem cells. Cell Prolif. 44 Suppl 1:9-14.
9. Strobl B, Stoiber D, Sexl V, and Müller M (2011). Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity. Front Biosci (Landmark Ed). 16:3214-32.
10. Friedbichler K, Themanns M, Mueller KM, Schlederer M, Kornfeld JW, Terracciano LM, Kozlov AV, Haindl S, Kenner L, Kolbe T, Mueller M, Snibson KJ, Heim MH, and Moriggl R (2012) Growth hormone-induced STAT5 signaling causes gigantism, inflammation and premature death but protects mice from aggressive liver cancer. Hepatology. 55:941-952.
11. Berry D, Schwab C, Milinovich G, Reichert J, Ben Mahfoudh K, Decker T, Engel M, Hai B, Hainzl E, Heider S, Kenner L, Müller M, Rauch I, Strobl B, Wagner M, Schleper C, Urich T, and Loy A (2012) Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J. 6: 2091-106.
12. Lanzén A, Jørgensen S, Huson D, Gorfer M, Grindhaug SH, Jonassen I, Øvreås L, and Urich T (2012) CREST – Classification resources for environmental sequence tags. PLoS ONE. 7:e49334.
13. Radax R, Rattei T, Lanzén A, Bayer C, Rapp HT, Urich T, and Schleper C (2012) Metatranscriptomics of the marine sponge Geodia barretti: Tackling phylogeny and function of its microbial community. Environ Microbiol 14:1308-1324.
14. Poulsen M, Schwab C, Jensen BB, Engberg RM, Spang A, Canibe N, Højberg O, Milinovich G, Fragner L, Schleper C, Weckwerth W, Lund P, Schramm A, and Urich T (2013) Methylotrophic methanogenic Thermoplasmata implicated in reduced methane emissions from bovine rumen. Nature Commun. 4:1428.
15. Berry D, Stecher B, Schintlmeister A, Reichert J, Brugiroux S, Wild B, Wanek W, Richter A, Rauch I, Decker T, Loy A, and Wagner M (2013) Host compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc Natl Acad Sci USA. 110: 4720–4725.
16. Berry D and Reinisch W (2013) Intestinal microbiota: a source of novel biomarkers in inflammatory bowel disease? Best Pract Res Cl Ga. 27: 47-58.
17. Stecher B, Berry D, and Loy A (2013) Colonization resistance and microbial ecophysiology: Using gnotobiotic mouse models and single-cell technology to explore the intestinal jungle. FEMS Microbiol Rev. 37: 793-829.
18. Yamamoto ML, Maier I, Dang AT, Berry D, Liu J, Ruegger PM, Yang J, Soto PA, Presley LL, Reliene R, Westbrook AM, Wei B, Loy A, Chang C, Braun J, Borneman J, and Schiestl RH (2013) Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leucocyte genotoxicity. Cancer Research. 73: 4222–4232.
19. Rauch I, Müller M, and Decker T (2013). The regulation of inflammation by interferons and their STATs. Jak‐Stat. 2: e23820.
20. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, and Berry D (2013) Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 108: 1620-1630.
21. Maier I, Berry D, and Schiesl R (2014) Intestinal microbiota reduces genotoxic endpoints induced by high-energy protons. Radiat. Res. 181: 45-53.
22. Schwab C, Berry D, Rauch I, Rennisch I, Ramesmayer J, Hainzl E, Heider S, Decker T, Kenner L, Müller M, Strobl B, Wagner M, Schleper C, Loy A, and Urich T (2014) Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J. 8:1101-14. doi: 10.1038/ismej.2013.223
23. Rauch I, Hainzl E, Rosebrock F, Heider S, Schwab C, Berry D, Stoiber D, Wagner M, Schleper C, Loy A, Urich T, Müller M, Strobl B, Kenner L, and Decker T (2014) Type I interferons have opposing effects during the emergence and recovery phases of colitis. Eur J Immunol. 44:2749-60. doi: 10.1002/eji.201344401
24. Schlederer M, Mueller KM, Haybaeck J, Heider S, Huttary N, Rosner M, Hengstschläger M, Moriggl R, Dolznig H, and Kenner L (2014) Reliable quantification of protein expression and cellular localization in histological sections. PLoS One. 9:e100822. doi: 10.1371/journal.pone.0100822
25. Rauch I, Rosebrock F, Hainzl E, Heider S, Majoros A, Wienerroither S, Strobl B, Stockinger S, Kenner L, Müller M, and Decker T (2015) Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons. Mol Cell Biol. 35:2332-43. doi: 10.1128/MCB.01498-14
26. Pencik J, Schlederer M, Gruber W, Unger C, Walker SM, Chalaris A, Marié IJ, Hassler MR, Javaheri T, Aksoy O, Blayney JK, Prutsch N, Skucha A, Herac M, Krämer OH, Mazal P, Grebien F, Egger G, Poli V, Mikulits W, Eferl R, Esterbauer H, Kennedy R, Fend F, Scharpf M, Braun M, Perner S, Levy DE, Malcolm T, Turner SD, Haitel A, Susani M, Moazzami A, Rose-John S, Aberger F, Merkel O, Moriggl R, Culig Z, Dolznig H, and Kenner L (2015) STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun. 6:7736. doi: 10.1038/ncomms8736
27. Hainzl E, Stockinger S, Rauch I, Heider S, Berry D, Lassnig C, Schwab C, Rosebrock F, Milinovich G, Schlederer M, Wagner M, Schleper C, Loy A, Urich T, Kenner L, Han X, Decker T, Strobl B, and Müller M (2015) Intestinal epithelial cell tyrosine kinase 2 transduces interleukin-22 signals to protect from acute colitis. J Immunol. in press
